|
No. |
Topic |
Summary |
Pages |
9645
| GMP Update by EMEA | - | 29 |
9646
| FDA Update | - | - |
9647
| GMP for Excipients | - | 28 |
9648
| Dedicated Facilities | - | - |
9649
| Qualification of Suppliers | - | 36 |
9650
| The PIC/S Guidances and the Role of PIC/S in International Harmonisation | - | 45 |
9651
| Session 1
Process Analytical Technology
| - | 126 |
9652
| Session 2
Pharmaceutical Quality Systems
| - | 49 |
9653
| Session 3
GMP in Early Phases of Development and Manufacture of IMPs
| - | 53 |
9654
| Session 4
Quality by Design
| - | 79 |
9655
| Session 5
The new Validation Approach
| - | 75 |
9656
| Session 6
EC GMP guideline Annex1 vs. FDA Aseptic Guide
| - | 94 |
